Roivant Sciences Limited
ROIV
ISIN BMG762791017 / Valor 113331044
Roivant Sciences Limited
UMushroom community rating:
About company
Roivant Sciences Limited is a biotech company that acquires drugs from larger pharmaceutical companies and focuses on developing them as standalone therapies through its subsidiary "vant" model. The company has experienced both failures and successes in its drug development efforts, including a notable late-stage setback in Alzheimer's disease and a successful $3 billion sale of five of its companies to Sumitomo Pharma. Roivant's approach capitalizes on the belief that large biotech and pharma companies can be too complex, creating opportunities for more focused companies to bring valuable treatments to market.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
8830 M
Market cap (USD)
2,183,285
Daily traded volume (Shares)
12.105 / 11.805
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
